12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

  • Magenta Therapeutics MGTA stock rose 41.3% to $0.8 during Thursday's after-market session. Trading volume for this security closed at 2.9 million, accounting for 164.9% of its average full-day volume over the last 100 days. The company's market cap stands at $48.3 million.
  • INVO Bioscience INVO stock rose 14.79% to $0.69. The market value of their outstanding shares is at $8.3 million.
  • Nymox Pharmaceutical NYMX stock increased by 11.11% to $0.5. The market value of their outstanding shares is at $45.2 million.
  • Aspira Womens Health AWH stock increased by 10.9% to $0.49. Aspira Womens Health's trading volume hit 117.9K shares by close, accounting for 53.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $60.8 million.
  • Processa Pharma PCSA stock moved upwards by 5.0% to $1.05. The market value of their outstanding shares is at $16.7 million.
  • Plus Therapeutics PSTV stock moved upwards by 5.0% to $0.43. The company's market cap stands at $14.4 million.

Losers

  • Avalo Therapeutics AVTX shares declined by 23.4% to $3.08 during Thursday's after-market session. The market value of their outstanding shares is at $28.9 million.
  • Cellectis CLLS shares fell 17.18% to $2.7. The company's market cap stands at $123.0 million.
  • SILO Pharma SILO stock fell 12.42% to $2.68. This security traded at a volume of 75.5K shares come close, making up 17.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
  • MEI Pharma MEIP shares declined by 7.96% to $0.31. The market value of their outstanding shares is at $40.8 million.
  • Biophytis BPTS stock declined by 7.79% to $0.65. Trading volume for this security closed at 11.8 million, accounting for 9508.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.3 million. As per the news, the H1 earnings report came out 2 days ago.
  • Virpax Pharmaceuticals VRPX shares declined by 7.41% to $1.0. The company's market cap stands at $11.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!